Methylmalonic acid (MMA) concentrations are increased in cobalamin (vitamin B12) deficiency, but the relative diagnostic usefulness of determination of MMA in serum vs urine has not yet been assessed. We obtained urine collections and matched serum samples from 28 healthy volunteers and from 20 consecutive patients admitted for clinical and hematological evaluation because of low cobalamin concentrations in serum. Increased concentrations of MMA in serum were found in 12 patients, in all of whom a clinical diagnosis of cobalamin deficiency was established. By contrast, cobalamin deficiency was excluded in seven of the eight remaining patients, who all had normal MMA concentrations. Here we report that linear relationships exist between MMA concentrations in serum (investigated range: 0.05-34.2 1imol/L) and MMA concentrations in urine (r = 0.74), concentrations relative to creatinine (r = 0.98), and MMA excretion rates (r = 0.97) (P <0.001 in each instance). Our data are consistent with glomerular filtration and passive reabsorption of MMA by the tubules. We demonstrate, for the first time, a negative correlation between concentrations of cobalamin and MMA in serum in clinical cobalamin deficiency (r = -0.69; P <0.01; n = 12); when the values for MMA were log transformed, the correlation with cobalamin was much better (r = -0.84; P <0.0005). (4, 5) . However, the relationship of the MMA concentration in urine to that in serum is unknown, but it must be established before urinary data can be unambiguously interpreted. As a result of newly developed analytical procedures,
MMA can now be reliably measured in serum (6, 7) . A significant advantage of the determination of MMA in serum as compared with its determination in urine is that the former is routinely collected in the process of evaluating patients for cobalainin deficiency, so serum specimens are usually available for additional studies in the clinical laboratory. 
SpecImens and Methods

Subjects
We obtained serum and matched 24-h urine collections from 28 overnight-fasted, healthy volunteers (14 men and 14 women, ages 22-86 y) and stared aliquots at -20 #{176}C until they could be analyzed.
Matched serum and urine specimens were collected from 20 patients (six men and 14 women, ages 26-82 y), consecutively selected on the basis of having cobalamin concentrations in serum below 100 pmol/L (normal range: 135-590 pmol/L), admitted for clinical and hematological evaluation at Aalborg Hospital, Denmark. In 15 of the patients, 18-h urine specimens were collected from 1300 to 0700 h, but it was not possible to obtain timed urine collections from five patients. All volunteers and patients had normal renal function (mean serum creatinine ± SD: 80 ± 11 and 77 ± 12 mo1JL, respectively).
Clinical diagnosis of cobalamin deficiency was made without knowledge of the MMA result (blinded test results), and MMA was measured without knowledge of clinical information (blinded clinical data). The criteria for clinical cobalamin deficiency were serum cobalamin concentration less than 100 pmolfL and one or both of the following: cobalamin absorption (Schilling) test result <10% and megaloblastic bone marrow morphology.
Determinations
MMA in serum and urine was determined by stableisotope-dilution with solid-phase extraction of the samples (7). The total analytical imprecision of our method (SD) is 0.026, 0.025, and 2.1 moUL at concentrations in serum of 0.07, 0.30, and 40 mol/L, respectively (7, 8) . Similar figures are obtained for urine. For serum and urine, the normal reference intervals are 0.08 to 0.56 j.tmoIJL and 0.58 to 3.56 mmol per mole of creatinine, respectively
. Creatinine in urine and in a serum sample obtained at the beginning of the urine collecting period was determined by the Technicon automated alkaline picrate method (9 In normomethylmalonic-acidemia, a weak positive correlation was obtained between age and MMA concentration in serum (r = 0.29; P <0.05; n = 36) and a highly Dashedlinesindicateupper referencelimits (7) forurinary excretion relativeto creatinine (3.56 mmol/mol creatinine) and for concentrationin serum ( O.56 mol/L) the urinary MMA excretion rate (r = 0.99; P <0.0005; n = 35). No correlations were found between urine pH, which ranged from 5.5 to 7.3, and urinary excretion of MMA, or fractional MMA clearance relative to creatinine. Similarly, no correlations were found between diuresis, which ranged from 33 to 128 mLfh, and fractional MMA clearance relative to creatinine, but a very weak correlation (r = 0.29; P <0.10; n = 32) was observed between diuresis and urinary
MMA excretion rate. No correlation was found between
concentrations of MMA, whether normal or increased, and fractional MMA clearance relative to creatinine. Table 1 compares the data on the investigated subgroups. Increased concentrations of MMA in serum and urine were found in 12 patients, in all of whom a clinical diagnosis of cobalamin deficiency was established.
By contrast, cobalamin deficiency was excluded in seven of the eight remaining patients, who all had normal values for MMA in serum. The diagnosis was uncertain in one patient with neurological abnormalities, in whom results for the Schilling test were abnormal (7%, normal 10%) but who had normal values for hemoglobin, mean cell volume, blood and bone-marrow smears, and for concentrations of MMA, folate, lactate dehydrogenase, iron, and transferrin in se-
rum.
Due to the criterion for selection, all 20 patients had low concentrations of cobalamin in serum. In patients with In hypermethylmalonic-acidemia, a negative correlation existed between concentrations of cobalamin and MMA in serum (r = -0.69; P <0.01; n = 12). In normomethylmalomc-acidemia, no significant correlation was found.
Discussion
It is evident from Figures 1 and 2 Together, these findings suggest that a complete 18-h to 24-h collection is necessary for valid estimation of urinary excretion of MMA and that the widespread use of determining the excretion of MMA in random (untimed) urine samples must be discouraged.
In clinical practice, however, 24-h collection of urine is difficult. Furthermore, there are other points in favor of testing serum. There is no need for an additional assay for creatimne, the dietary influences in serum in normal man are far less marked than in urine (8), and, as already mentioned, measurements can be done on serum that remains after determination of cobalamin. There is no reason to believe that MMA as a small (molecular mass = 118 g/mol) and very polar dicarboxylic acid is bound to plasma proteins. Therefore, some information about the renal handling of MMA can be gained from our data. The fractional clearance ratio relative to creatinine is lower than 1, defining net reabsorption.
There is no dependence of the fractional MMA clearance on the serum concentration, and the correlations from From their data, a fractional MMA clearance ratio of 0.78 can be calculated. Marcell et al. (6) found a mean fractional MMA clearance ratio of 0.28 (range and SD were not reported) for spot urine samples from normal subjects. They argued that this observation supported their concept that most of the MMA in serum is metabolized via unknown pathways, as has been observed in experiments in which [methyl-"Cjmalonic acid was administered to rats via intracardial injections [apparently unpublished results, cited in (11)]. However, the simplest explanation of a fractional clearance ratio lower than 1 is renal reabsorption, possibly by passive transport, because the urine-to-serum ratio for MMA was never less than 1 (see Figures 1 and 2) , because the fractional MMA clearance was independent of concentration in serum, and because the urinary excretion rate varied with urine flow rate (although with weak correlation). Urine-to-serum gradients for acids can also be generated by pH gradients, but We were able to demonstrate a good, significant correlation between the cobalamin assay and determination of MMA in serum from the 12 patients with hypermethylmalonic-acidemia (r = -0.69; P <0.01). In normomethylmalonic-acidemia, no significant correlation was found. Because the normal reference interval for concentrations of MMA in serum is log-normally distributed (6, 7), we calculated the correlations between cobalamin concentrations and the logarithm of the individual values for MMA in serum and obtained much better correlation in hypermethylmalonic-acidemia (r = -0.84; P <0.0005; n = 12), but still no convincing correlation was obtained in normomethylmalonic-acidemia (P >0.25). The present work, however, was not designed to assess the diagnostic sensitivity and specificity of serum cobalamin assays. Further studies to elucidate this problem are contemplated. 
